NASDAQ$WGS

GeneDx Holdings Corp · Q3 2025 earnings

Q3 2025 earnings ·

Briefing

GeneDx Holdings reported Q3 2025, revenue of $116.7M, net loss of $7.6M.

For Q3 2025, GeneDx Holdings reported revenue of $116.7M, a net loss of $7.6M. The filing discusses segment trends, liquidity, and management outlook for upcoming periods.

  • Revenue $116.7M.
  • Net loss $7.6M.
  • GeneDx Holdings highlights operating priorities and capital allocation.

Headline financials

Total Revenue

$117M

Previous: $76.9M+51.9%
EPS (adj)

$0.27

Previous: -$0.31+187.1%
Capital Expenditures

-$14.7M

Previous: -$2.44M-501.0%
Free Cash Flow

-$22.3M

Previous: -$10.8M-107.4%
Net Income

-$7.64M

Previous: -$8.31M+8.1%
Operating Income

-$3.25M

Previous: -$7.78M+58.2%
Gross Profit

$84.5M

Previous: $47.8M+76.7%

Revenue & EPS history

GeneDx Holdings Corp · Revenue · Quarterly

$117M

Q3 2025+51.9%vs Q3 2024
Beat estimate in 1 of 2 quarters(50%)
ActualEstimate

Forward guidance

The release discusses GeneDx Holdings's outlook, capital allocation, and key risks for upcoming quarters, including guidance ranges or operating priorities where disclosed.

Tailwinds

  • GeneDx Holdings cites demand and execution supporting the near-term outlook.
  • Liquidity and balance-sheet capacity support operations and shareholder returns.

Headwinds

  • GAAP profitability remained under pressure in Q3 2025.
  • Macro, input costs, and FX may pressure margins quarter to quarter.
  • Segment mix and one-time items can affect comparability versus prior periods.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 14 quarterly earnings reports · overlaid with Q3 2025

Historical avgQ3 2025

-0.2%

Avg return

Earnings day

-7.5%

Avg return

5 days after

-10.6%

Avg return

30 days after

36%

5 / 14 earnings

Positive

+49.9%

Q3 2024

Best reaction

-42.8%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.8%-37.6%-18.8%
Q4 2025+6.1%-2.9%-18.4%
Q3 2025+5.2%+4.8%+26.7%
Q1 2025-42.8%-43.4%-39.1%
Q3 2024+49.9%+38.7%+41.7%
Q2 2024-10.6%-10.7%-3.6%
Q1 2024-0.7%+77.4%+90.9%
Q3 2023-1.1%-20.7%-2.2%
Q2 2023-0.6%-21.2%-34.1%
Q1 2023-5.6%-22.2%-24.3%
Q3 2022-12.2%-39.0%-70.8%
Q2 2022-1.2%-51.0%-58.8%
Q1 2022+10.3%+32.1%+1.9%
Q3 2021-2.5%-9.2%-39.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro